| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8218639 | International Journal of Radiation Oncology*Biology*Physics | 2014 | 9 Pages |
Abstract
ERBB 2 overexpression appears relevant to CRT resistance and unfavorable CSS in MIBC patients treated with the CRT-based bladder-sparing protocol. ERBB 2-targeting treatment may improve the outcomes of such patients.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Masaharu MD, Fumitaka MD, PhD, Soichiro MD, PhD, Tomoki MT, Yasuhisa MD, PhD, Eisaku MD, PhD, Kazunori MD, PhD,